Notice2023-08246
Advisory Committee on Immunization Practices (ACIP)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
April 18, 2023
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with regulatory provisions, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public. Time will be available for public comment.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 74 (Tuesday, April 18, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 74 (Tuesday, April 18, 2023)]
[Notices]
[Pages 23678-23679]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-08246]
[[Page 23678]]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2023-0028]
Advisory Committee on Immunization Practices (ACIP)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with regulatory provisions, the Centers for
Disease Control and Prevention (CDC) announces the following meeting of
the Advisory Committee on Immunization Practices (ACIP). This meeting
is open to the public. Time will be available for public comment.
DATES: The meeting will be held on April 19, 2023, 11 a.m. to 3 p.m.,
EDT (date and times subject to change; see the ACIP website for
updates: <a href="https://www.cdc.gov/vaccines/acip/index.htm">https://www.cdc.gov/vaccines/acip/index.htm</a>).
Written comments must be received on or before April 19, 2023.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-
0028, by either of the methods listed below. CDC does not accept
comments by email.
<bullet> Federal eRulemaking Portal: <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Follow the instructions for submitting comments.
<bullet> Mail: ACIP Meeting, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, Mailstop H24-8, Atlanta, Georgia
30329-4027. Attn: Docket No. CDC-2023-0028.
Instructions: All submissions received must include the Agency name
and docket number. All relevant comments received in conformance with
the <a href="https://www.regulations.gov">https://www.regulations.gov</a> suitability policy will be posted
without change to <a href="https://www.regulations.gov">https://www.regulations.gov</a>, including any personal
information provided. For access to the docket to read background
documents or comments received, go to <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
The meeting will be webcast live via the World Wide Web. The
webcast link can be found on the ACIP website at <a href="https://www.cdc.gov/vaccines/acip/index.html">https://www.cdc.gov/vaccines/acip/index.html</a>.
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, Committee Management
Specialist, Advisory Committee on Immunization Practices, National
Center for Immunization and Respiratory Diseases, Centers for Disease
Control and Prevention, 1600 Clifton Road NE, Mailstop H24-8, Atlanta,
Georgia 30329-4027. Telephone: (404) 639-8836; Email: <a href="/cdn-cgi/l/email-protection#18595b5148587b7c7b367f776e"><span class="__cf_email__" data-cfemail="f2b3b1bba2b2919691dc959d84">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Fewer than 15 calendar days' notice is being
given for this meeting in accordance with 41 CFR 102-3.150(b).
Following a discussion between CDC and the Food and Drug Administration
regarding anticipated regulatory changes to the COVID-19 vaccination
program, a decision was made late Monday, April 10, 2023, that it is
essential for ACIP to have a public committee meeting to discuss and
get input from the Committee members. This meeting is critical in order
for the rationale for these changes to be conveyed to the public in a
timely and efficient manner. Further, given the continuing COVID-19
pandemic, it is essential that all decision-making regarding vaccines
be done as urgently as possible. A notice of the meeting has also been
posted on the ACIP website at <a href="https://www.cdc.gov/vaccines/acip/index.html">https://www.cdc.gov/vaccines/acip/index.html</a>. In addition, CDC has sent notice of the meeting by email to
those who subscribe to receive email updates about ACIP.
Purpose: The Advisory Committee on Immunization Practices (ACIP) is
charged with advising the Director, Centers for Disease Control and
Prevention (CDC), on the use of immunizing agents. In addition, under
42 U.S.C. 1396s, the Committee is mandated to establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to vaccine-eligible children through the Vaccines
For Children program, along with schedules regarding dosing interval,
dosage, and contraindications to administration of vaccines. Further,
under applicable provisions of the Affordable Care Act and section 2713
of the Public Health Service Act, immunization recommendations of ACIP
that have been approved by the Director, CDC, and appear on CDC
immunization schedules generally must be covered by applicable health
plans.
Matters To Be Considered: The agenda will include discussions on
COVID-19 vaccines. No recommendation votes are scheduled. Agenda items
are subject to change as priorities dictate. For more information on
the meeting agenda, visit <a href="https://www.cdc.gov/vaccines/acip/meetings/index.html">https://www.cdc.gov/vaccines/acip/meetings/index.html</a>.
Meeting Information: The meeting will be webcast live via the World
Wide Web. For more information on ACIP, please visit the ACIP website:
<a href="https://www.cdc.gov/vaccines/acip/index.html">https://www.cdc.gov/vaccines/acip/index.html</a>.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Please note that
comments received, including attachments and other supporting
materials, are part of the public record and are subject to public
disclosure. Comments will be posted on <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Therefore, do not include any information in your comment or supporting
materials that you consider confidential or inappropriate for public
disclosure. If you include your name, contact information, or other
information that identifies you in the body of your comments, that
information will be on public display. CDC will review all submissions
and may choose to redact, or withhold, submissions containing private
or proprietary information such as Social Security numbers, medical
information, inappropriate language, or duplicate/near-duplicate
examples of a mass-mail campaign. CDC will carefully consider all
comments submitted into the docket.
Written Public Comment: Written comments must be received on or
before April 19, 2023.
Oral Public Comment: This meeting will include time for members of
the public to make an oral comment. Priority will be given to
individuals who submit a request to make an oral public comment before
the meeting according to the procedures below.
Procedure for Oral Public Comment: All persons interested in making
an oral public comment at the April 19, 2023, ACIP meeting must submit
a request at <a href="https://www.cdc.gov/vaccines/acip/meetings/index.html">https://www.cdc.gov/vaccines/acip/meetings/index.html</a> no
later than 11:59 p.m., EDT, April 17, 2023, according to the
instructions provided.
If the number of persons requesting to speak is greater than can be
reasonably accommodated during the scheduled time, CDC will conduct a
lottery to determine the speakers for the scheduled public comment
session. CDC staff will notify individuals regarding their request to
speak by email on April 18, 2023. To accommodate the significant
interest in participation in the oral public comment session of ACIP
meetings, each speaker will be limited to three minutes, and each
speaker may only speak once per meeting.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and
[[Page 23679]]
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-08246 Filed 4-14-23; 4:15 pm]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on April 18, 2023.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.